Skip to main content
. 2011 Sep 6;64(3):168–174. doi: 10.5173/ceju.2011.03.art17

Table 3.

Frequencies of CDKN2A variants in controls and in the bladder cancer group

CDKN2A Debniak et.al (n=1210) controls This study (n=156) G test (table 2×2)
A148T A/A 0 (0%) A/G 35 (2.89%) G/G 1175 (97.1%) Allele A frequency 1.5% A/A 1 (0.64%) A/G 8 (5.13%) G/G 147 (94.23%) Allele A frequency 3.2% G= 4.298
p<0.05